Gene electrotransfer in clinical trials.

Electroporation is increasingly being used for delivery of chemotherapy to tumors. Likewise, gene delivery by electroporation is rapidly gaining momentum for both vaccination purposes and for delivery of genes coding for other therapeutic molecules, such as chronic diseases or cancer. This chapter describes how gene therapy may be performed using electric pulses to enhance uptake and expression.

[1]  Richard Heller,et al.  Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  Faisal Mahmood,et al.  Preclinical validation of electrochemotherapy as an effective treatment for brain tumors. , 2011, Cancer research.

[3]  Julie Gehl,et al.  Gene electrotransfer to skin; review of existing literature and clinical perspectives. , 2010, Current gene therapy.

[4]  J. Gehl,et al.  Spatial distribution of transgenic protein after gene electrotransfer to porcine muscle. , 2012, Human gene therapy methods.

[5]  C. Collins,et al.  Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the CliniporatorTM by means of invasive or non-invasive electrodes , 2006 .

[6]  D. Weiner,et al.  Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques. , 2008, Vaccine.

[7]  M. Rols,et al.  In vivo electrically mediated protein and gene transfer in murine melanoma , 1998, Nature Biotechnology.

[8]  M. Bureau,et al.  High-efficiency gene transfer into skeletal muscle mediated by electric pulses. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J. Gehl,et al.  Proof of Concept of Gene Therapy Using Plasmid Amep in Disseminated Melanoma: Safety and Efficacy Results of A Phase I First-In-Man Study , 2012 .

[10]  D Miklavcic,et al.  Efficiency of high- and low-voltage pulse combinations for gene electrotransfer in muscle, liver, tumor, and skin. , 2008, Human gene therapy.

[11]  Robert Strange,et al.  Electroporation-Mediated Gene Transfer Directly to the Swine Heart , 2012, Gene Therapy.

[12]  E. Neumann,et al.  Gene transfer into mouse lyoma cells by electroporation in high electric fields. , 1982, The EMBO journal.

[13]  J. Gimble,et al.  Competitive electroporation formulation for cell therapy , 2011, Cancer Gene Therapy.

[14]  J. Gehl,et al.  Calcium electrotransfer for termination of transgene expression in muscle. , 2011, Human gene therapy.

[15]  S. Welle,et al.  Neonatal oxygen increases sensitivity to influenza A virus infection in adult mice by suppressing epithelial expression of Ear1. , 2012, The American journal of pathology.

[16]  J. Gehl,et al.  Duration and level of transgene expression after gene electrotransfer to skin in mice , 2010, Gene Therapy.

[17]  P Raskmark,et al.  In vivo electroporation of skeletal muscle: threshold, efficacy and relation to electric field distribution. , 1999, Biochimica et biophysica acta.

[18]  M J Jaroszeski,et al.  Electroporation-mediated delivery of a naked DNA plasmid expressing VEGF to the porcine heart enhances protein expression , 2010, Gene Therapy.

[19]  V. Sondak,et al.  Phenotypic and functional analysis of dendritic cells and clinical outcome in patients with high-risk melanoma treated with adjuvant granulocyte macrophage colony-stimulating factor. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  J. Gehl,et al.  Management of cutaneous metastases using electrochemotherapy , 2011, Acta oncologica.